The CLO of Aduro BioTech (NASDAQ: ADRO) is Selling Shares

Today, the CLO of Aduro BioTech (ADRO – Research Report), Templeman Blaine, sold shares of ADRO for $3,636. In addition to Templeman Blaine, 2 other ADRO executives reported Sell trades in the More »

Cantor Fitzgerald Believes KalVista Pharmaceuticals Inc (NASDAQ: KALV) Won’t Stop Here

In a report released today, Charles Duncan from Cantor Fitzgerald reiterated a Buy rating on KalVista Pharmaceuticals Inc (KALV – Research Report), with a price target of $32. The company’s shares opened More »